ELAN - solider Wert viel Potential - 500 Beiträge pro Seite

[HenryIV]

Schaut Euch mal Elan (WKN: 871331) an.
Eigentlich ein Pharmawert, der aber auch im Biotechsektor
aktiv ist und ein Mittel gegen Alzheimer entwickelt.

Das Unternehmen macht gute Gewinne (KGV 2000 von 40)und hat
eine Marktkapitalisierung von ca. 14 Mrd. $.

Die neuesten Nachrichten in Bezug auf das Alzheimermedikament
scheinen sehr gut zu sein. Trotzdem hat die Aktie nicht
entsprechend reagiert.

Eure Meinung ?????

HenryIV

[niceguy11]

momentan noch! ein Geheimtipp, der langsam den Weg nach oben geht !
investiert sein und abwarten.

[only4fun]

Princeton, New Jersey, July 12 (Bloomberg Data) -- Elan Corp Plc -spons Adr (ELN US) was reiterated short-term ``outperform`` by analyst Jeffrey J Kraws at Gruntal & Co. The long-term rating was also reiterated ``outperform.`` The short/long-term target prices are $58/$70 per share.

Princeton, New Jersey, July 14 (Bloomberg Data) -- Elan Corp Plc (ELN US) was reiterated ``buy`` by analyst Kenneth R. Nover at A.G. Edwards & Sons Inc. The price target is $66.00 per share.

[only4fun]

Washington, July 16 (Bloomberg) -- The U.S. National Institutes of Health will receive an additional $50 million over the next five years for Alzheimer`s disease research, the Associated Press reported, citing a statement from President Bill Clinton. The funds are to build on findings released last week by the pharmaceutical company Elan Corp., which said that preliminary results from the first human study of a possible Alzheimer`s vaccine suggests the compound is safe, AP said. Scientists said it is too soon to tell if the vaccine will help Alzheimer`s patients, the news agency said.

The Alzheimer`s Association said in a statement today that Congress should increase appropriations for Alzheimer`s research for fiscal year 2001 by $100 million.

(AP 7/16).